HealthCare Global Enterprises Limited (NSE:HCG)
712.55
+21.95 (3.18%)
At close: Sep 9, 2026
NSE:HCG Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹806.80. The average 1-year stock price forecast is 13.23% higher than the current stock price, while the lowest is ₹724.00 (+1.61%) and the highest is ₹920.00 (+29.11%).
Price Target: ₹806.80 (+13.23%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 7 | 8 | 9 | 9 | 9 |
| Buy | 3 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 9 | 10 |
Financial Forecast
Revenue This Year
29.01B
from 25.45B
Increased by 13.96%
Revenue Next Year
33.33B
from 29.01B
Increased by 14.89%
EPS This Year
9.27
from 3.59
Increased by 157.99%
EPS Next Year
14.85
from 9.27
Increased by 60.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.